BIOXYTRAN, INC Quarterly Debt-to-equity in % from Q1 2014 to Q2 2022

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Bioxytran, Inc quarterly Debt-to-equity history and growth rate from Q1 2014 to Q2 2022.
Bioxytran, Inc Debt-to-equity for the quarter ending June 30, 2022 was -116 %, a 3.68% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2022	-116	+4.44	+3.68%	Jun 30, 2022
Q1 2022	-125	-16.3	-15%	Mar 31, 2022
Q4 2021	-124	-19.7	-18.8%	Dec 31, 2021
Q3 2021	-131	-27	-26%	Sep 30, 2021
Q2 2021	-121	-15.4	-14.6%	Jun 30, 2021
Q1 2021	-109	-0.86	-0.8%	Mar 31, 2021
Q4 2020	-105	+7.84	+6.96%	Dec 31, 2020
Q3 2020	-104	+4.56	+4.2%	Sep 30, 2020
Q2 2020	-105	+7.56	+6.7%	Jun 30, 2020
Q1 2020	-108	+207	+65.8%	Mar 31, 2020
Q4 2019	-113	-196	-236%	Dec 31, 2019
Q3 2019	-109	-147	-383%	Sep 30, 2019
Q2 2019	-113	-220	-205%	Jun 30, 2019
Q1 2019	-314	+133	+29.8%	Mar 31, 2019
Q4 2018	83.2	+195		Dec 31, 2018
Q3 2018	38.4	+151		Sep 30, 2018
Q2 2018	107	+221		Jun 30, 2018
Q1 2018	-448	-328	-274%	Mar 31, 2018
Q4 2017	-112	+12.6	+10.2%	Dec 31, 2017
Q3 2017	-113	+14.4	+11.3%	Sep 30, 2017
Q2 2017	-114	+22.2	+16.3%	Jun 30, 2017
Q1 2017	-120	+21.2	+15.1%	Mar 31, 2017
Q4 2016	-124	+20.6	+14.2%	Dec 31, 2016
Q3 2016	-127	+23	+15.3%	Sep 30, 2016
Q2 2016	-136	+29.2	+17.6%	Jun 30, 2016
Q1 2016	-141	+79.2	+36%	Mar 31, 2016
Q4 2015	-145	+496	+77.4%	Dec 31, 2015
Q3 2015	-150	-897	-120%	Sep 30, 2015
Q2 2015	-166	+371	+69.2%	Jun 30, 2015
Q1 2015	-220	+146	+39.8%	Mar 31, 2015
Q4 2014	-641			Dec 31, 2014
Q3 2014	747			Sep 30, 2014
Q2 2014	-537			Jun 30, 2014
Q1 2014	-366			Mar 31, 2014

* An asterisk sign (*) next to the value indicates that the value is likely invalid.